Align Technology

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures

Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms

Why Eli Lilly and Company is stockpiling a weight loss pill before the FDA has even said yes

Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue

Joe Hogan adds to Align stake with fresh $1m stock purchase, defying macro headwinds

Align Technology CEO Joe Hogan purchases $1M in stock, signaling long-term confidence. Find out how this insider buy reflects broader digital dentistry trends.

byPallavi Madhiraju

August 3, 2025

Align Technology launches Invisalign system with mandibular advancement featuring occlusal blocks in Asia-Pacific

Discover how Align Technology’s new mandibular advancement Invisalign system is transforming Class II treatment—and why analysts are optimistic.

byPallavi Madhiraju

July 22, 2025

The Latest

Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures

Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms

Why Eli Lilly and Company is stockpiling a weight loss pill before the FDA has even said yes

Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue

Joe Hogan adds to Align stake with fresh $1m stock purchase, defying macro headwinds

Align Technology launches Invisalign system with mandibular advancement featuring occlusal blocks in Asia-Pacific

Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures

Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms

Why Eli Lilly and Company is stockpiling a weight loss pill before the FDA has even said yes

Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue

Sumitomo Forestry expands U.S. housing footprint with $4.5bn Tri Pointe Homes acquisition

Applied Optoelectronics Inc. Texas expansion marks next phase in optical components reshoring push

What Patrick Dumont’s rise to CEO reveals about Las Vegas Sands Corp.’s post-founder strategy

What Medtronic’s Stealth AXiS FDA clearance signals for surgical navigation and robotics competition